Business EconomyPosted at: Jun 25 2025 7:23PM


Gujarat-based Sudeep Pharma Limited files DRHP for IPO

Hyderabad, June 25 (UNI) Gujarat-based Sudeep Pharma, a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries, has filed its draft red herring prospectus (DRHP) with capital market regulator Securities and Exchange Board of India (SEBI) to mop up funds through an initial public offering (IPO).
The IPO, with a face value of Rs 1 each, combines fresh issuance of Rs 95 crore with an offer for sale of up to 1,00,76,492 equity shares by the Promoter Selling Shareholder.
The offer for sale consists of up to 35,67,670 equity shares by Sujit Jaysukh Bhayani, up to 50,04,622 equity shares by Sujeet Jaysukh Bhayani HUF, up to 7,50,000 equity shares by Shanil Sujit Bhayani, and up to 7,54,200 equity shares by Avani Sujit Bhayani.
The company, in consultation with the book-running lead managers, may consider an issue of specified securities, aggregating to Rs 19 crores as pre-IPO placement shall not exceed 20 per cent of the size of the fresh issue.
If such placement is completed, the fresh issue size will be reduced.
The offer is being made through the book-building process, wherein not more than 50 per cent of the offer shall be available for allocation on a proportionate basis to qualified institutional buyers, not less than 15 percent of the offer shall be available for allocation to non-institutional bidders, and not less than 35 percent of the offer shall be available for allocation to retail individual bidders.
The proceeds from its fresh issuance to the extent of Rs 75.81 crore for capital expenditure towards procurement of machinery for its production line located at Nandesari Facility I; and general corporate purposes.
The company has expanded its operations from production of excipients to a wide variety of over 100 products in the pharmaceutical, food and nutrition industries, as of December 31, 2024. Its business is primarily structured into two verticals, Pharmaceutical, food and nutrition and Specialty ingredients.
The company operates three Manufacturing Facilities in Vadodara, Gujarat, with a combined annual manufacturing capacity of 65,579 MT.
For the nine-month period ended December 31, 2024, revenue from operations and profit after tax stood at Rs 344.45 crore and Rs 94.54 crore respectively.
UNI KNR RN
Tags: #Gujarat-based Sudeep Pharma Limited files DRHP for IPO
More News

Gujarat-based Sudeep Pharma Limited files DRHP for IPO

25 Jun 2025 | 7:23 PM

Hyderabad, June 25 (UNI) Gujarat-based Sudeep Pharma, a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries, has filed its draft red herring prospectus (DRHP) with capital market regulator Securities and Exchange Board of India (SEBI) to mop up funds through an initial public offering (IPO).

see more..
Sensex zooms up by 700 40 points to 82,755 51 amidst firm Asian cues, cooling crude oil prices

Sensex zooms up by 700 40 points to 82,755 51 amidst firm Asian cues, cooling crude oil prices

25 Jun 2025 | 6:02 PM

Mumbai, June 25 (UNI) The BSE Sensex today jumped by 700.40 points to close positive at 82,755.51, tracking firm cue from Asian peers and easing crude oil prices, traders said Easing tensions in the Middle East following a tentative ceasefire between Israel and Iran lifted investor sentiments, traders added

see more..

Lupin gets approval from U S FDA for Prucalopride Tablets

25 Jun 2025 | 5:53 PM

Hyderabad, June 25 (UNI) Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Prucalopride Tablets, 1 mg, and 2 mg. Prucalopride Tablets
are bioequivalent to Motegrity® Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals U.S.A. Inc.

see more..

Rupee slips 10 paise to 86 07 against US dollar

25 Jun 2025 | 5:50 PM

Mumbai, Jun 25 (UNI) Rupee today depreciated by 10 paise to close at 86.07 against the US
dollar, on strong dollar demand by bankers and importers, forex traders said
Positive close in the domestic equity market limited the rupee fall, traders added
The currency opened 4 paise higher at 86.01 against the dollar. It closed the previous session at 85.97
The partially convertible rupee recorded intra-day high and low at 85.90 and 86.14 respectively, dealers added.

see more..

Cognizant announces major expansion to establish new campus in Visakhapatnam

25 Jun 2025 | 5:07 PM

Visakhapatnam, June 25 (UNI) Cognizant, a global leader in technology and professional services, today announced a major expansion of its India operations with plans to develop a state-of-the-art campus here in Andhra Pradesh.

see more..